Trial intelligence / Profile preview

Isoflurane and neuroinflammation in children with hydrocephalus

NCT02512809Phase 3Terminated

Sponsor
Nationwide Children's Hospital
Start
Jul 2015
Primary completion
Oct 2017
Modality
Allosteric Modulators
01

Overview

A Phase 3 trial of isoflurane, sponsored by Nationwide Children's Hospital. Started Jul 2015; status: terminated.

02

Drugs

isoflurane

Beyond the preview

Go deeper on NCT02512809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02512809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call